Glenmark Pharmaceuticals saw the highest growth of 399% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 399% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Glenmark Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Glenmark Pharmaceuticals has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with 11 publications in Q4 2023
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings and grants with nearly 65% filings and 0% grants. The World Intellectual Property Organization(WIPO), United States(US), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Glenmark Pharmaceuticals is filings its patents. Among the top granted patent authorities, Glenmark Pharmaceuticals has 33% of its grants in United States(US), 33% in Japan(JP) and 17% in Australia(AU).
Amgen and Sanofi could be the strongest competitors for Glenmark Pharmaceuticals
See Also:
Patents related to rare diseases and nanomedicine lead Glenmark Pharmaceuticals's portfolio
Glenmark Pharmaceuticals has the highest number of patents in rare diseases followed by, nanomedicine. For rare diseases, nearly 100% of patents were filed and 75% of patents were granted in Q4 2023.
Rhinitis related patents lead Glenmark Pharmaceuticals portfolio followed by petrochemicals, and multiple myeloma (kahler disease)
Glenmark Pharmaceuticals has highest number of patents in rhinitis followed by petrochemicals, multiple myeloma (kahler disease), allergic rhinitis, and acne and related disorders. For rhinitis, nearly 29% of patents were filed and 22% of patents were granted in Q4 2023.
For comprehensive analysis of Glenmark Pharmaceuticals's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
